HomeCompareMSVB vs PFE

MSVB vs PFE: Dividend Comparison 2026

MSVB yields 100.62% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MSVB wins by $48963646543237.41M in total portfolio value
10 years
MSVB
MSVB
● Live price
100.62%
Share price
$17.69
Annual div
$17.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48963646543237.45M
Annual income
$48,870,344,522,135,495,000.00
Full MSVB calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — MSVB vs PFE

📍 MSVB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMSVBPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MSVB + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MSVB pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MSVB
Annual income on $10K today (after 15% tax)
$8,552.85/yr
After 10yr DRIP, annual income (after tax)
$41,539,792,843,815,170,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, MSVB beats the other by $41,539,792,843,815,140,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MSVB + PFE for your $10,000?

MSVB: 50%PFE: 50%
100% PFE50/50100% MSVB
Portfolio after 10yr
$24481823271618.75M
Annual income
$24,435,172,261,067,760,000.00/yr
Blended yield
99.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MSVB
No analyst data
Altman Z
0.1
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MSVB buys
0
PFE buys
0
No recent congressional trades found for MSVB or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMSVBPFE
Forward yield100.62%6.20%
Annual dividend / share$17.80$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$48963646543237.45M$51.1K
Annual income after 10y$48,870,344,522,135,495,000.00$27,210.54
Total dividends collected$48957522261011.74M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MSVB vs PFE ($10,000, DRIP)

YearMSVB PortfolioMSVB Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$30,824$20,124.36$9,161$701.38+$21.7KMSVB
2$148,930$115,947.80$8,610$859.79+$140.3KMSVB
3$1,206,475$1,047,119.88$8,366$1,081.25+$1.20MMSVB
4$17,146,397$15,855,468.88$8,483$1,405.66+$17.14MMSVB
5$439,538,448$421,191,803.43$9,084$1,907.24+$439.53MMSVB
6$20,651,652,012$20,181,345,872.27$10,418$2,732.78+$20651.64MMSVB
7$1,794,466,782,028$1,772,369,514,375.24$13,007$4,193.56+$1794466.77MMSVB
8$289,779,942,406,244$287,859,862,949,474.50$18,010$7,005.87+$289779942.39MMSVB
9$87,198,150,562,584,220$86,888,086,024,209,540.00$28,216$12,979.89+$87198150562.56MMSVB
10$48,963,646,543,237,456,000$48,870,344,522,135,495,000.00$51,081$27,210.54+$48963646543237.41MMSVB

MSVB vs PFE: Complete Analysis 2026

MSVBStock

Mid-Southern Bancorp, Inc. operates as the holding company for Mid-Southern Savings Bank, FSB that provides various banking products and services to individuals and business customers. It accepts various deposit products, including checking, savings, money market, and demand accounts, as well as certificates of deposit and term deposits. The company also offers loans secured by first mortgages on one- to four-family residences, including home equity loans and lines of credit; commercial and multifamily real estate loans; construction loans secured by single-family residences; commercial and multifamily real estate loans; land and lot loans; commercial business loans; consumer loans, including new and used manufactured homes, automobiles and truck, boats, and motorcycles and recreational vehicle loans; loans secured by savings deposits and other personal loans; and unsecured consumer loans. In addition, it holds and manages an investment securities portfolio. The company provides its products and services through its main office in Salem; and through its branch offices located in Mitchell and Orleans, Indiana, as well as through loan production offices located in New Albany, Indiana and Louisville, Kentucky. The company was founded in 1886 and is headquartered in Salem, Indiana.

Full MSVB Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MSVB vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MSVB vs SCHDMSVB vs JEPIMSVB vs OMSVB vs KOMSVB vs MAINMSVB vs JNJMSVB vs MRKMSVB vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.